Maria D. Ribadeneira

Maria Ribadeneira is an accomplished pharmaceutical professional with extensive experience in drug metabolism and pharmacokinetics (DMPK), clinical pharmacology, and safety. Currently serving as VP DMPK at Sionna Therapeutics since March 2023, Maria has also provided consulting services for project out-licensing at Novo Nordisk. Previously, Maria held leadership roles at FORMA Therapeutics, Ironwood Pharmaceuticals, Boehringer Ingelheim, AstraZeneca, and DuPont Pharmaceuticals, contributing to the development of novel therapeutic agents and managing cross-functional teams. Maria possesses a PhD in Physiology with a focus on Renal Physiology from Georgia State University and a BS in Biology and Chemistry from The University of Alabama in Huntsville.